EUVIMEDOpdag EUVIMED
Crossref

Next‐generation sequencing using tissue specimen collected with a 1.1 mm‐diameter cryoprobe in patients with lung cancer

Mi-Hyun Kim, Soo Han Kim, Geewon Lee, Jeongha Mok, Min Ki Lee iD, Ju Sun Song, Jung Seop Eom iD

Respirology · 2024-04 · 29 (4) · 333-339

DOI: 10.1111/resp.14680 ↗

At a glance

Journal article in Respirology, published online on 2024-02-20. Written by Mi-Hyun Kim and 6 co-authors. Institution: Department of Internal Medicine, Pusan National University School of Medicine, Busan, Republic of Korea. Major MEDLINE topics: Lung Neoplasms. Cited 14 times so far (Crossref); 30 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Objective Next‐generation sequencing (NGS) analysis is considered standard for lung cancer diagnosis in clinical practice. Little is known about the feasibility of NGS using tumour tissue sampled with a 1.1 mm‐diameter cryoprobe. We aimed to investigate the suitability of specimens obtained by transbronchial cryobiopsy (TBC) using a 1.1 mm‐diameter cryoprobe for NGS analysis.

Methods

Patients with lung cancer who underwent TBC using a 1.1 mm‐diameter cryoprobe for NGS testing between October 2020 and April 2023 were enrolled. A 4.0‐ or 3.0 mm‐diameter bronchoscope with radial probe endobronchial ultrasound and virtual bronchoscopic navigation was used to detect peripheral lung lesions. All procedures were performed under fluoroscopic guidance. Data were analysed retrospectively.

Results

A total of 56 patients underwent TBC using a 1.1 mm cryoprobe for NGS testing, during the study period. Most patients (98%) were in the advanced stage of lung cancer (recurrent or inoperable disease of stages III or IV). The diagnostic yield of NGS for DNA and RNA sequencing was 95% each (53 of 56). Moderate bleeding was noted in three patients (5%) and none of the study patients developed life‐threatening complications, such as pneumothorax or lung infection.

Conclusion

TBC using a 1.1 mm‐diameter cryoprobe is a useful and safe tool for NGS analysis, for both DNA and RNA sequencing. image

Subjects

MeSH terms (MEDLINE)

Lung NeoplasmsHumansRetrospective StudiesBronchoscopyLungHigh-Throughput Nucleotide SequencingDNABiopsy

Author keywords

next-generation sequencingnon-small cell lung cancerradial probe endobronchial ultrasoundtransbronchial cryobiopsy

Substances

DNA

Authors and institutions

  • Department of Internal Medicine, Pusan National University School of Medicine, Busan, Republic of Korea.
  • Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
  • Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
  • Department of Radiology, Pusan National University School of Medicine, Busan, Republic of Korea.
  • Department of Radiology, Pusan National University Hospital, Busan, Republic of Korea.
  • GC Genome Corporation, Yongin, Republic of Korea.

ORCID profiles: Min Ki Lee, Jung Seop Eom

Cite

APA

Kim, M. H., Kim, S. H., Lee, G., Mok, J., Lee, M. K., Song, J. S., & Eom, J. S. (2024). Next‐generation sequencing using tissue specimen collected with a 1.1 mm‐diameter cryoprobe in patients with lung cancer. Respirology, 29(4), 333-339. https://doi.org/10.1111/resp.14680

Vancouver

Kim MH, Kim SH, Lee G, Mok J, Lee MK, Song JS, et al. Next‐generation sequencing using tissue specimen collected with a 1.1 mm‐diameter cryoprobe in patients with lung cancer. Respirology. 2024;29(4):333-339. doi:10.1111/resp.14680

BibTeX
@article{Kim2024,
  author = {Kim, Mi-Hyun and Kim, Soo Han and Lee, Geewon and Mok, Jeongha and Lee, Min Ki and Song, Ju Sun and Eom, Jung Seop},
  title = {Next‐generation sequencing using tissue specimen collected with a 1.1 mm‐diameter cryoprobe in patients with lung cancer},
  journal = {Respirology},
  year = {2024},
  volume = {29},
  number = {4},
  pages = {333--339},
  doi = {10.1111/resp.14680}
}
Start for free →